#Wegovy is an active hashtag on Bluesky. In the last 30 days, 38 people shared 70 posts with it — around 2 a day. Activity is up 7% versus the previous week, peaking on Jul 16 with 10 posts.

Posts with #Wegovy

Dan Brierley

@drdanbrierley.bsky.social

over 1 year ago

Really proud to start the year by sharing our new review in @endosocjournals.bsky.social on the roles of GLP-1 in eating and obesity treatment, led by superstar postdoc @laurenjonesucl.bsky.social! academic.oup.com/endo/art…. 🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic

academic.oup.com

GLP-1 and the Neurobiology of Eating Control: Recent Advances

Abstract. Obesity is now considered a chronic relapsing progressive disease, associated with increased all-cause mortality that scales with body weight, af

5 24 92

puppy is in Paris

@mireaze.bsky.social

about 2 months ago

Time to start fundraising for next month already 😭 If you wanna help me lose weight to get bottom surgery please support and share!!! 🥺🐶👉👈 Linktr.ee/Mireaze #Trans #MA #Wegovy #BottomSurgery

Wegovy 1mg

£149.99

Continue at your current dose to maintain steady progress and minimise side effects.

1 67 75

Current Biology

@currentbiology.bsky.social

over 1 year ago

Everyone is talking about #Ozempic #Wegovy which are agonists of the GLP-1 receptor. For more about this receptor and its physiological role, see the quickguide by Michael Krashes in our latest issue www.cell.com/current-biol...

www.cell.com

Glucagon-like peptide-1 receptor

Michael Krashes discusses glucagon-like peptide-1 receptors, their physiological role in glucose metabolism and the mode of action of their agonists that are used to treat obesity and were later shown...

2 18 59

André Picard @picardonhealth

@picardonhealth.bsky.social

about 1 year ago

Provinces should cover weight-loss drug for people with pre-existing cardiovascular disease, says Canada's Drug Agency. CDA says #Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20%, by @kellygrant1.bsky.social www.theglobeandmail.com/c…. via @theglobeandmail.com

www.theglobeandmail.com

Provinces should cover weight-loss drugs for people with pre-existing cardiovascular disease, says drug agency

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent

5 18 55

Rozenn Le Saint

@rozennlesaint.bsky.social

11 months ago

«L’obésité est une maladie de pauvres dont un traitement efficace n’est accessible qu’aux riches» : #Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé. Des médecins prescrivent son anti-diabétique, l’ #Ozempic, aux moins riches. Enquête sur ce système D. www.mediapart.fr/journal/….

www.mediapart.fr

Obésité : ces médecins qui rusent pour soigner les moins aisés

Le médicament anti-obésité Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé en France alors que la maladie touche davantage les populations précaires. Des médecins prescrivent son traitement…

4 32 55

ThePupRookie

@thepuprookie.bsky.social

over 1 year ago

It’s Friday time for my weekly shot. #Wegovy

1 1 37

midgardfinance.com

@midgardfinance.com

2 days ago

🇩🇰 $NOVO is close to a one-molecule company. Semaglutide is 76% of sales worldwide and 87% in the US. #Ozempic alone is 40% of the company, #Wegovy injectable another 25%. Insulin and rare disease together are the remainder. midgardfinance.com/compan… #pharma #semaglutide $NVO

Three line charts side by side on a dark background, titled "Novo Nordisk semaglutide as a share of sales". The panels are World, US and Ex-US. The vertical axis is share of all Novo Nordisk sales, from zero to about ninety percent, and each panel runs from late 2020 to mid 2026.

Three lines in each panel. Violet is semaglutide counted across all its brands, which are Ozempic, Wegovy injectable, Wegovy pill and the oral diabetes tablet sold as Rybelsus or Ozempic pill. Light blue is Ozempic alone. Green is Wegovy injectable alone.

Worldwide, semaglutide climbs from under 20 percent in 2020 to 76 percent of all company sales. Ozempic alone rises to about 40 percent and has been flat for roughly two years. Wegovy injectable climbs steadily to about 25 percent.

In the US the same lines are higher and further along: semaglutide reached about 90 percent during 2025 and stands near 87 percent, having eased back from its peak. Ex-US semaglutide is lower at about 63 percent but still rising, and the Wegovy line there is still climbing steeply rather than levelling off.

The three panels together show one company increasingly dependent on a single molecule, with the US furthest into that dependence and the rest of the world following.

1 0 3

Sarah P Davis

@sarahsfineart.bsky.social

about 1 year ago

‘The Road to Mounjaro’. Soft pastel artwork on pastelmat 30x40cms. A depiction of my own personal experience with weight loss. #mounjaro #wegovy #orlistat #xenical #art #elephants #city #weightloss #diet #pastels #carandache #carbothello #fatshaming #bullying #artwork #artistsofbluesky #nhs #uk

Pastel artwork called ‘The Road to Mounjaro’ depicting an elephant walking down the middle of a busy road in the city lit up with neon lights reflecting on the elephant and the road she walks on. The picture is about the artists own struggles with weight loss.

0 4 28

Terra Field

@rainofterra.gay

almost 2 years ago

LOL FINALLY Anybody who has been on it knew everything they said about how it worked was wrong but we didn’t care because it was incredible. It actually raises the basal metabolic rate, which for me was always incredibly low when I got it tested. Not anymore! 🎉 #semaglutide #wegovy #ozempic

www.newsweek.com

Ozempic works differently than previously thought, study reveals

Ozempic, Wegovy, Mounjaro and other weight loss drugs work by boosting metabolism and suppressing appetite, a new trial suggests.

7 3 27

midgardfinance.com

@midgardfinance.com

about 1 hour ago

🇩🇰 $NOVO sales shrinking in the US and growing everywhere else. Trailing 12-month sales: #Ozempic: DKK 82bn in the US, down from a 94bn peak 📉 #Wegovy injectable: 45bn, down from 53bn 📉 Outside the US both are at record highs, 40bn and 35bn. midgardfinance.com/compan… #pharma $NVO

Two line charts side by side on a dark background, titled "Novo Nordisk GLP-1 and obesity, trailing twelve months". The left panel is the US, the right panel is Ex-US. The vertical axis, shared by both, is trailing twelve-month sales in billions of Danish kroner, and each panel runs from 2021 to mid 2026.

Six lines per panel, each labelled at its right-hand end: Ozempic, Wegovy injectable, Wegovy pill, the oral diabetes tablet Rybelsus, Saxenda and Victoza.

The US panel is where the two big lines turn. Ozempic rises from about 20 billion kroner in 2021 to a peak of about 94 billion in the middle of 2025, then falls to about 82. Wegovy injectable peaks at about 53 billion in the same quarter and falls to about 45. Rybelsus drifts down from about 12 billion to 8. Wegovy pill, launched in January 2026, lifts off the axis at the very end.

The Ex-US panel shows the opposite. Both large lines are at their highest points on the chart at the right-hand edge and still rising, Ozempic at about 40 billion kroner and Wegovy injectable at about 35 billion. Rybelsus sits at about 12 billion.

Read together, the same two products are declining in the US and setting records everywhere else. There is no World panel because it would only restate the sum of these two.

1 1 2

Mike on a Mission

@mike-on-a-mission2.bsky.social

over 1 year ago

Hey y’all, is there much of a #GLP1community here? Might be a future TikTok refugee and looking for a new home to talk #mounjaro #zepbound #ozempic #wegovy. Is there life out there in Blue Sky? Anyone??

8 2 23

Nicolas Berrod

@nicolasberrod.bsky.social

over 1 year ago

Bonne nouvelle pour 3 000 patients "en continuité de traitement contre l’obésité" : ils bénéficieront gratuitement du #Wegovy "jusqu'à fin 2025 au plus tard, dans l’attente de la négociation du prix pour permettre un remboursement en droit commun" (après le feu vert de la HAS).